George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.
The U.S. Food and Drug Administration (FDA) recently approved the drug Epidiolex, which contains cannabidiol (CBD), as an oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy—Lennox-Gastaut syndrome and Dravet syndrome—in patients two years of age and older (1).
EVIO Labs Florida (Broward County, Florida) was recently recognized for their participation in The Emerald Test (Emerald Scientific), which is an interlaboratory comparison and proficiency assessment for cannabis testing.
The 2018 Cannabis Science Conference will be held August 27–29, in Portland, Oregon.
Cannabis strains may have just been given the fast track to a pharmaceutical version (pill form) that captures the entire strain specific effects through the use of a device termed the lossless activation chamber Y (LACY).
Thomas Jefferson University Announces Initiative to Study Health Outcomes in Medical Cannabis Patients
On Monday, May 14, 2018, Pennsylvania became the first state to add opioid addiction to its list of approved conditions for medicinal cannabis.
Whether you are just starting out in the cannabis industry and looking to setup a grow facility, or you are a veteran in the field, one thing is clear: Advancements in lighting, design, cultivation, and technology abound for grow faciliti
One of the most promising new medicinal treatment options in modern history was quietly freed just months after it was roughly handcuffed and hauled off to jail by a Justice Department memo.
The online news service NJ Spotlight hosted a half-day event on May 11, 2018, at the Hilton Garden Inn in Hamilton, New Jersey, titled “Marijuana Legalization in NJ: Understanding the Opportunity and Challenges.” The event was sponsored b